—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Novonesis (Novozymes) A/S (NSIS-B.CO) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for NSIS-B.CO, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 61/100 · S&P 500 fund at 75, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-10-06
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 98th percentile of the window, +5.7% over 20 sessions. Factor regime → 2026-10-06
  • Sector × region Materials in Europe: +2.6% week · +1.5% month · +2.7% quarter · +22.7% year (approximated)The Sector Engine cell this name lives in, from EXV3.XETRA+EXH6.XETRA+EXH3.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-10-06
  • Sovereign pressure Index 0.74 · up 0.17 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-10-06
Who it is priced against Specialty Chemicals · 8 names with week and year-to-date

Peer group

Specialty Chemicals

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against NSIS-B.CO on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Novonesis (Novozymes) A/S

NSIS-B.CO in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Novonesis, formerly Novozymes, develops and supplies industrial enzymes, microorganisms and functional proteins used across food, agriculture, cleaning and bioenergy production. Its enzymes help turn crops into biofuel, improve detergents and support health and nutrition products. The company is based in Lyngby, Denmark, and serves customers across food and beverage, agriculture, household care and human health markets worldwide.
Where it sits in the stack
Novonesis carries no seat in our index; it sits in the specialty chemicals corner of the Basic Materials sector the diary tracks outside the build-out. Its work in industrial biotechnology and enzyme science falls well outside the layers we map for the AI hardware and infrastructure chain.
Who it is priced against
Closelooknet's peer group places it among other scored Basic Materials names, a broad sector comparison rather than a direct match, drawn from gold miners such as Barrick and AngloGold Ashanti. The market's closer comparison is International Flavors & Fragrances, whose Danisco unit competes directly in enzymes.
Why Closelooknet tracks it
It carries a Closelooknet score with momentum as its strongest module and valuation as its weakest, but holds no seat in our index and has not appeared in the diary's editions or quotes.
What the diary watches
Whether demand for bioenergy and industrial enzyme applications shifts enough to move the valuation module, given the gap between its momentum and valuation readings.

Novonesis (Novozymes) A/S (NSIS-B.CO) trades on the CO exchange in Denmark, classified under Basic Materials.

The Closelooknet company score reads 47/100 composite (momentum 64, quality 50, valuation 18) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 1.53%, semi-annual · buybacks 100 m DKK in FY2025

Dividends and capital return

What NSIS-B.CO pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 6.60 DKK per share · a 1.53% yield on the 2026-10-06 close 2 distributions, paid twice a year 2026-10-06
  • Change on the year +2.3% against the prior twelve months prior twelve months 6.45 DKK per share
  • Last distribution 2.35 DKK per share as the price series records it, within days of the ex-date 2026-08-25
  • By calendar year 2025: 6.45 DKK (partial) · 2026: 6.60 DKK to date first distribution recorded in the three-year window: 2025-04-04
  • Dividends paid, FY2025 403 m DKK 49% of earnings
  • Buybacks, FY2025 100 m DKK 0.0% of today's market value
  • Share count +1.6% in FY2025 20 m DKK of stock-based compensation in the year
  • Capital returned 503 m DKK · 67% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-10-07

Quick answers

What is Novonesis (Novozymes) A/S (NSIS-B.CO)?

Novonesis (Novozymes) A/S trades as NSIS-B.CO on the CO exchange (Denmark) and is classified under Basic Materials in the Closelooknet research universe, as of the registry build of 2026-10-07.

Is NSIS-B.CO in a Closelooknet index?

Not currently — Novonesis (Novozymes) A/S is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-10-07.

What is Novonesis (Novozymes) A/S's Closelooknet composite score?

47 out of 100, with momentum 64, quality 50 and valuation 18 sub-scores, as of 2026-10-07. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does NSIS-B.CO trade against its moving averages?

Uptrend stack intact: Trades +0.1% vs the 50-day and +8.5% vs the 200-day average, 7.3% below the 52-week high and +30.2% off the 52-week low; a golden cross printed 67 sessions ago. Computed from daily closes. As of 2026-10-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Novonesis (Novozymes) A/S compare with its peers?

Against its peer group (Specialty Chemicals), Novonesis (Novozymes) A/S (NSIS-B.CO) sits 7.3% below its 52-week high, 0.1% above its 50-day average; Sasol Ltd (SSL) is 5.9% below, Azelis Group NV (AZE.BR) is 3.8% below, Dyno Nobel Ltd (DNL.AU) is 4.7% below. Put any of them next to NSIS-B.CO in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

What does Novonesis (Novozymes) A/S do?

Novonesis, formerly Novozymes, develops and supplies industrial enzymes, microorganisms and functional proteins used across food, agriculture, cleaning and bioenergy production. Its enzymes help turn crops into biofuel, improve detergents and support health and nutrition products. The company is based in Lyngby, Denmark, and serves customers across food and beverage, agriculture, household care and human health markets worldwide. Closelooknet's peer group places it among other scored Basic Materials names, a broad sector comparison rather than a direct match, drawn from gold miners such as Barrick and AngloGold Ashanti. The market's closer comparison is International Flavors & Fragrances, whose Danisco unit competes directly in enzymes.

Where does Novonesis (Novozymes) A/S sit in the AI build-out?

Novonesis carries no seat in our index; it sits in the specialty chemicals corner of the Basic Materials sector the diary tracks outside the build-out. Its work in industrial biotechnology and enzyme science falls well outside the layers we map for the AI hardware and infrastructure chain. It carries a Closelooknet score with momentum as its strongest module and valuation as its weakest, but holds no seat in our index and has not appeared in the diary's editions or quotes.

Does Novonesis (Novozymes) A/S pay a dividend?

Novonesis (Novozymes) A/S has paid 6.60 DKK per share over the last twelve months, paid twice a year, a trailing yield of 1.53% on the 2026-10-06 close; the last distribution recorded in the price series was 2.35 DKK on 2026-08-25. In fiscal 2025 the company paid 403 m DKK in dividends and bought back 100 m DKK of its own shares, 67% of that year’s free cash flow. The share count rose 1.6% over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for NSIS-B.CO, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Specialty Chemicals. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.